Role of Sodium-glucose Linked Transporter 2 (SGLT2) and Its Inhibitor Over CARdiotoxicity Induced by Anthracyclines and Breast Cancer Tumorigenesis SCARA-B

Abroad (travel likely)Recruiting

Conditions

Breast Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Centre Paul Strauss, Strasbourg, France
Contact: Study coordinator (Hervé BISCHOFF, MD) · h.bischoff@institut-strauss.fr
Study coordinator · promotion-rc@institut-strauss.fr
Contact: Principal Investigator (Hervé BISCHOFF)

Study leads

Hervé BISCHOFF
Principal Investigator
Centre Paul Strauss

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Carcinoma, Non-Small Cell Lung · Squamous Cell Carcinoma of Head and Neck · HER2 Negative Breast Neoplasms

Abroad (travel likely)RecruitingPHASE1

Anchorage, United States · Fayetteville, United States

PREgnancy and FERtility Registry

Breast Neoplasms · Pregnancy · Fertility Preservation

Abroad (travel likely)Recruiting

Asti, Italy · Brindisi, Italy

Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery

Triple Negative Breast Neoplasms

Abroad (travel likely)RecruitingPHASE2

Amiens, France · Avignon, France

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Advanced Solid Tumor · Metastatic Solid Tumor · Refractory Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Sarasota, United States · Boston, United States